Novel therapies in clinical use for the management of hyperlipidaemia
Optimal control of low-density lipoprotein cholesterol (LDLc) is identified as a major target in reducing cardiovascular disease burden globally. However, existing lipid-lowering therapies have not been able to achieve LDLc targets even in developed countries. Therefore, novel therapies for the mana...
Saved in:
Main Author: | C. Mettananda (Author) |
---|---|
Format: | Book |
Published: |
Sri Lanka College of Internal Medicine,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Silent hyperlipidaemia modulated vascular endothelial markers
by: Marwan Merkhan, et al.
Published: (2021) -
The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy
by: Maharani F. Iskandar, et al.
Published: (2018) -
Clinical and biochemical comparative study between alternate and every day clofibrate - lovastatin combination therapy on mixed hyperlipidaemia
by: Al - Mousilly M. Maiada, et al.
Published: (2004) -
Studies Regarding The Bidirectional Relationship Between The Periodontal Disease And Hyperlipidaemia
by: Amelia Macovei-Surdu, et al.
Published: (2013) -
Comparison of the efficacy and safety of Shanhuang Jiangzhi tablets and atorvastatin in the treatment of patients with hyperlipidaemia
by: GuoTong Sun, et al.
Published: (2023)